ANI Pharmaceuticals, Inc. Reports 36% Decline In Q4 Bottom Line

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) reported earnings for fourth quarter that decreased from last year.

The company said its earnings dropped to $6.04 million, or $0.52 per share. This was lower than $9.45 million, or $0.82 per share, in last year's fourth quarter.

The company said revenue for the quarter fell 14.3% to $18.04 million. This was down from $21.04 million last year.

ANI Pharmaceuticals, Inc. earnings at a glance:

-Earnings (Q4): $6.04 Mln. vs. $9.45 Mln. last year. -Earnings Decline (Y-o-Y): -36.1% -EPS (Q4): $0.52 vs. $0.82 last year. -EPS Decline (Y-o-Y): -36.6% -Revenue (Q4): $18.04 Mln vs. $21.04 Mln last year. -Revenue Change (Y-o-Y): -14.3%